NCT05014139
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 recruiting NCT00722553
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder treatment 2 completed NCT01215877
Tesetaxel for Previously Treated Patients With Bladder Cancer treatment 2 unknown_status NCT03288545
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer treatment 1 / 2 active_not_recruiting NCT03410693
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 / 3 completed NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 completed NCT05318339
A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT01856101
Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy treatment 2 terminated NCT01189838
The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma No drug interventions Not Available Not Available unknown_status NCT05874921
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto Not Available Not Available recruiting NCT03219333
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer treatment 2 completed NCT02793128
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study No drug interventions treatment 3 completed NCT01529411
Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer treatment 2 completed NCT00191971
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen treatment 2 completed NCT00077688
TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium treatment 2 completed NCT02014337
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors treatment 1 completed NCT00101842
Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer treatment 1 / 2 completed NCT02443324
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer treatment 1 completed NCT02450331
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection treatment 3 terminated NCT03051373
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract treatment 2 completed NCT00146276
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer treatment 3 unknown_status NCT04039867
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer treatment 2 terminated NCT00172367
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma prevention 2 withdrawn NCT02300610
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer treatment 1 completed NCT00001381
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder treatment 1 completed NCT00127595
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract treatment 2 terminated NCT00109655
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure treatment 1 unknown_status NCT02451423
Neoadjuvant Atezolizumab in Localized Bladder Cancer treatment 2 completed NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors treatment 2 active_not_recruiting NCT01310803
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder treatment 3 terminated NCT03238664
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors No drug interventions treatment Not Available withdrawn NCT00154687
Weekly TP-HDFL in the Treatment of Advanced TCC treatment 2 completed NCT03256877
Detecting Transitional Cell Carcinoma From Haematuria No drug interventions Not Available Not Available completed NCT02160600
Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial No drug interventions diagnostic Not Available completed NCT01668459
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel treatment 2 / 3 completed NCT00070070
Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas treatment 1 completed NCT03296306
Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma treatment 3 unknown_status NCT01215136
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma treatment 2 terminated NCT00880334
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC treatment 2 completed NCT01395225
Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer No drug interventions Not Available Not Available completed NCT00612326
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging No drug interventions Not Available Not Available completed NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen No drug interventions treatment 1 completed NCT03927573
Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker No drug interventions treatment 1 terminated NCT04006691
Efficacy and Safety of UGN-101 in Recurrent Patients No drug interventions treatment 3 withdrawn NCT01200992
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer treatment 3 terminated NCT01103544
JAVLOR® Online Non-Interventional Trial No drug interventions Not Available Not Available completed NCT05052372
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib Not Available Not Available terminated NCT04811846
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood No drug interventions treatment Not Available recruiting NCT01438112
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer treatment 2 / 3 terminated NCT04179110
Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor treatment 2 withdrawn NCT00389155
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy treatment 2 / 3 completed NCT00101608
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium treatment 2 completed NCT02420847
Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery treatment 1 / 2 active_not_recruiting NCT02471547
Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT No drug interventions treatment Not Available unknown_status NCT02109328
Alisertib in Chemotherapy-pretreated Urothelial Cancer treatment 2 completed NCT03193788
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy treatment 3 unknown_status NCT00696007
Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer treatment 2 withdrawn NCT00683059
Single Agent Abraxane as Second Line Therapy in Bladder Cancer treatment 2 completed NCT03219775
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma treatment 2 unknown_status NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT00714025
A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy treatment 2 completed NCT02887248
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma treatment 2 terminated NCT02581982
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer treatment 2 completed NCT00173862
Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC treatment 2 completed NCT00633789
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types treatment 2 completed NCT00216801
Relationship of Ochratoxin A to Upper Urologic Cancers No drug interventions Not Available Not Available completed NCT06462001
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer treatment 3 active_not_recruiting NCT04878250
Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder treatment 2 not_yet_recruiting